Alcon Inc. Ordinary Shares
ALCAlcon Inc. is a global leader in eye care, specializing in the development, manufacturing, and marketing of ophthalmic products including surgical devices, eye care, and contact lenses. Founded in Switzerland, the company has a strong presence worldwide and is known for its innovations in vision care and eye health solutions.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 15, 2025 | $0.28 | 2025-05-14 | 2025-05-14 |
| May 16, 2024 | $0.24 | 2024-05-14 | 2024-05-15 |
| May 12, 2023 | $0.21 | 2023-05-10 | 2023-05-11 |
| May 5, 2022 | $0.20 | 2022-05-03 | 2022-05-04 |
| May 6, 2021 | $0.10 | 2021-05-04 | 2021-05-05 |
Dividends Summary
- Consistent Payer: Alcon Inc. Ordinary Shares has rewarded shareholders with 5 dividend payments over the past 4 years.
- Total Returned Value: Investors who held ALC shares during this period received a total of $1.03 per share in dividend income.
- Latest Payout: The most recent dividend of $0.28/share was paid 253 days ago, on May 15, 2025.
- Yield & Schedule: ALC currently pays dividends yearly with an annual yield of 0.35%.
- Dividend Growth: Since 2021, the dividend payout has grown by 180.0%, from $0.10 to $0.28.
- Growth Streak: ALC has raised its dividend for 5 consecutive payments.
Company News
The global contact lens market is projected to grow from USD 18.88 billion in 2025 to USD 26.64 billion by 2033, expanding at a CAGR of 4.42%. Growth is driven by rising myopia prevalence, increasing adoption of disposable lenses, and technological advancements in silicone hydrogel materials. However, risks from eye infections and user discomfort...
STAAR Surgical shares declined as Broadwood Partners, which owns 31% of the company, gained board influence with two new directors joining alongside Christopher Wang of Yunqi Capital. The changes follow the failed merger with Alcon and include the departure of Chair Elizabeth Yeu, with CEO Stephen Farrell remaining until January 31, 2026. The sto...
The global LASIK eye surgery market is projected to grow from USD 2.25 billion in 2025 to USD 3.77 billion by 2033, at a CAGR of 6.68%. Growth is driven by rising refractive disorders, AI-enabled surgical innovations, and expanding healthcare infrastructure. However, concerns over long-term safety complications such as corneal thinning and dry ey...
The global intraocular lens market is projected to grow from USD 5.97 billion in 2025 to USD 9.85 billion by 2033, driven by rising cataract prevalence, aging populations, and advanced lens technologies. However, high costs of premium lenses and limited accessibility in developing regions remain key challenges. North America leads the market with...
STAAR Surgical announced that shareholders did not approve its merger with Alcon Inc., which was valued at approximately $1.6 billion. The deal will be terminated with no termination fees owed by either party. STAAR will remain a standalone publicly traded company and focus on profitable growth and expanding its EVO ICL technology globally. Major...
